Analysis of prognostic value of complete response by PET-CT and further stratification by clinical and biological markers in DLBCL patients.

about

Analysis of prognostic value of complete response by PET-CT and further stratification by clinical and biological markers in DLBCL patients.

Item

http://www.wikidata.org/entity/Q40373396

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Analysis of prognostic value o ...... cal markers in DLBCL patients.

@en

type

Item

label

Analysis of prognostic value o ...... cal markers in DLBCL patients.

@en

prefLabel

Analysis of prognostic value o ...... cal markers in DLBCL patients.

@en

P1476

Analysis of prognostic value o ...... cal markers in DLBCL patients.

@en

P2093

Miho Tamura

http://www.w3.org/2001/XMLSchema#string

Takeshi Sawada

http://www.w3.org/2001/XMLSchema#string

Tatsu Shimoyama

http://www.w3.org/2001/XMLSchema#string

Tsunekazu Hishima

http://www.w3.org/2001/XMLSchema#string

Yasushi Omuro

http://www.w3.org/2001/XMLSchema#string

Yoshiharu Maeda

http://www.w3.org/2001/XMLSchema#string

Yuki Sasaki

http://www.w3.org/2001/XMLSchema#string

P2860

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

Stromal gene signatures in large-B-cell lymphomas

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Evaluating cell-of-origin subtype methods for predicting diffuse large B-cell lymphoma survival: a meta-analysis of gene expression profiling and immunohistochemistry algorithms

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).

Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma

Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium.

P2888

s12032-017-0885-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-017-0885-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yusuke Kanemasa

P577

2017-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1051996553

http://www.w3.org/2001/XMLSchema#string

P698

28083854

http://www.w3.org/2001/XMLSchema#string